Orally administered 50mg GRACEVIT (sitafloxacin) tablets entered the market in Thailand from March 5, 2012.
Sitafloxacin (GRACEVIT), which belongs to the same class of drugs as levofloxacin, maintains remarkable microbiological eradication rates, even against highly resistant pathogens.

GRACEVIT is indicated for the following infections in Thailand.